Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Heilbron Jack Kendrick SQFT Presidio Property Trust, Inc. 13D 7.8% 2y
AQR CAPITAL MANAGEMENT LLC SUAC ShoulderUp Technology Acquisition Corp. 13G 12% 2y
STATE STREET CORP KRC Kilroy Realty Corp 13G/A 5.43% 2y
Perry A. Sook NXST Nexstar Media Group, Inc. 13G 5.2% 2y
Aspex Management (HK) Ltd QFIN Qfin Holdings, Inc. 13G/A 5.3% 2y
Group of Trophy, LLC GIPR Generation Income Properties, Inc. 13G/A 0% 2y
BBAI Ultimate Holdings, LLC BBAI BigBear.ai Holdings, Inc. 13D/A 75.2% 2y
Hood River Capital Management LLC DCGO DocGo Inc. 13G/A 1.7% 2y
Trilogy Equity Partners, LLC OWLT Owlet, Inc. 13D/A 23.9% 2y
Smiths Group plc ICUI Icu Medical Inc 13D/A 6.9% 2y
First City Investment Group, LLC GIPR Generation Income Properties, Inc. 13G 6.8% 2y
Alessandra T. Norcross FRBK Republic First Bancorp Inc 13D/A 3.7% 2y
BCLS II Investco, LP NAMS NewAmsterdam Pharma Co N.V. 13D/A 6% 2y
Blackstone Inc. APG APi Group Corp 13D/A 4.8% 2y
BRC Group Holdings, Inc. MCHX Marchex Inc 13G/A 4% 2y
Charles F. Dolan SPHR Sphere Entertainment Co. 13D/A 12.9% 2y
BIOS EQUITY PARTNERS, LP LTRN Lantern Pharma Inc. 13D/A 11.8% 2y
Morris Willner ARKO ARKO Corp. 13D/A 9.74% 2y
David R. Parker and Jacqueline F. Parker CVLG Covenant Logistics Group, Inc. 13D/A 30.8% 2y
Elliott Investment Management L.P. BTU Peabody Energy Corp 13D/A 4.6% 2y
Coliseum Capital Management, LLC GMS GMS Inc. 13D/A 4.9% 2y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 16.8% 2y
VIKING GLOBAL INVESTORS LP APG APi Group Corp 13G/A 12.3% 2y
JAY S. HENNICK CIGI Colliers International Group Inc. 13D/A 13.1% 2y
Ariel Emanuel EDR Endeavor Group Holdings, Inc. 13D/A 11.9% 2y
GP Cash Management, Ltd. IZEA IZEA Worldwide, Inc. 13G 6.1% 2y
David T. Lu BHM Bluerock Homes Trust, Inc. 13G/A 8.7% 2y
Nelson Michael Aaron BLPH Bellerophon Therapeutics, Inc. 13G 5.3% 2y
Aperture Healthcare Ventures Ltd. PTHS Pelthos Therapeutics Inc. 13G 7.7% 2y
3i, LP PTHS Pelthos Therapeutics Inc. 13G 5.5% 2y
AME Equities LLC PTHS Pelthos Therapeutics Inc. 13G 6.4% 2y
Benuvia Operations, LLC PTHS Pelthos Therapeutics Inc. 13G 6.7% 2y
Motif Pharmaceuticals Ltd. PTHS Pelthos Therapeutics Inc. 13G 8.4% 2y
PERCEPTIVE ADVISORS LLC IOVA Iovance Biotherapeutics, Inc. 13G 6.9% 2y
683 Capital Management, LLC MODD Modular Medical, Inc. 13G 6.99% 2y
WOLVERINE ASSET MANAGEMENT LLC FTII FutureTech II Acquisition Corp. 13G/A 4.44% 2y
Rosalind Advisors, Inc. PYPD PolyPid Ltd. 13G 9.95% 2y
WOLVERINE ASSET MANAGEMENT LLC IRRX Integrated Rail and Resources Acquisition Corp. 13G/A 2.61% 2y
WOLVERINE ASSET MANAGEMENT LLC SBC SBC Medical Group Holdings Inc 13G/A 0% 2y
Suntone Investment Pty Ltd WELNF Integrated Wellness Acquisition Corp 13D 69.6% 2y
Peter Luo ADAG Adagene Inc. 13D/A 21.28% 2y
Quarry LP SEDA SDCL EDGE Acquisition Corporation 13G 7.5% 2y
Carl Daikeler BODI Beachbody Company, Inc. 13D/A 38.7% 2y
PERCEPTIVE ADVISORS LLC CRNX Crinetics Pharmaceuticals, Inc. 13D/A 1.9% 2y
Sachem Head Capital Management LP USFD US Foods Holding Corp. 13D/A 6.5% 2y
ZUU Co. Ltd. SBC SBC Medical Group Holdings Inc 13D/A 25.5% 2y
DE AGOSTINI SPA BRSL Brightstar Lottery PLC 13D/A 42.6% 2y
Panasonic Holdings Corporation NMG Nouveau Monde Graphite Inc. 13G 17% 2y
Point72 Asset Management, L.P. LUNG Pulmonx Corp 13G 5% 2y
Saba Capital Management, L.P. DHF Bny Mellon High Yield Strategies Fund 13D/A 4.11% 2y